Plasma and tissue pharmacokinetics of marbofloxacin in experimentally infected chickens with Mycoplasma gallisepticum and Escherichia coli

作者: H. Ding , L. Wang , X. Shen , X. Gu , D. Zeng

DOI: 10.1111/JVP.12049

关键词:

摘要: The plasma and tissue pharmacokinetics of marbofloxacin in chickens experimentally infected with Mycoplasma gallisepticum Escherichia coli were studied. Marbofloxacin was given to 66 by oral administration at a dosage 5 mg/kg b.w., once day for three days. Plasma, brain, kidney, liver, lung, muscle trachea collected concentrations analyzed high performance liquid chromatography method. In the chickens, maximal plasma, 1.84, 1.33, 7.35, 5.61, 3.12, 2.98, 4.51 g/mL (g); elimination half-lives 6.8, 2.74, 9.31, 8.45, 9.55, 11.53 5.46 h trachea, respectively. AUC calculated be 9.68, 8.04, 45.1, 27.03, 20.56, 19.47, 32.68 μg/mL (g) concentration tissues except brain exceeded AUC(tissue) /AUC(plasma) ranging from 2.01 4.66 Peak(tissue) /Peak(plasma) 1.62 3.99. results showed that administered orally 24 intervals may provide successful treatment chicken MG E. infection.

参考文章(13)
L. G. YUAN, R. WANG, L. H. SUN, L. X. ZHU, X. Y. LUO, J. SUN, B. H. FANG, Y. H. LIU, Pharmacokinetics of marbofloxacin in Muscovy ducks (Cairina moschata). Journal of Veterinary Pharmacology and Therapeutics. ,vol. 34, pp. 82- 85 ,(2011) , 10.1111/J.1365-2885.2010.01207.X
M. SCHNEIDER, V. THOMAS, B. BOISRAME, J. DELEFORGE, Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration Journal of Veterinary Pharmacology and Therapeutics. ,vol. 19, pp. 56- 61 ,(1996) , 10.1111/J.1365-2885.1996.TB00009.X
E. Thomas, E. Grandemange, P. Pommier, S. Wessel‐Robert, J.L. Davot, Field evaluation of efficacy and tolerance of a 2% marbofloxacin injectable solution for the treatment of respiratory disease in fattening pigs. Veterinary Quarterly. ,vol. 22, pp. 131- 135 ,(2000) , 10.1080/01652176.2000.9695041
M. SPRENG, J. DELEFORGE, V. THOMAS, B. BOISRAMÉ, H. DRUGEON, Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. Journal of Veterinary Pharmacology and Therapeutics. ,vol. 18, pp. 284- 289 ,(1995) , 10.1111/J.1365-2885.1995.TB00592.X
E. Thomas, G. L. Caldow, D. Borell, J. L. Davot, A field comparison of the efficacy and tolerance of marbofloxacin in the treatment of bovine respiratory disease Journal of Veterinary Pharmacology and Therapeutics. ,vol. 24, pp. 353- 358 ,(2001) , 10.1046/J.1365-2885.2001.00333.X
Lefebvre, Schneider, Dupouy, Laroute, Costes, Delesalle, Toutain, EFFECT OF EXPERIMENTAL RENAL IMPAIRMENT ON DISPOSITION OF MARBOFLOXACIN AND ITS METABOLITES IN THE DOG Journal of Veterinary Pharmacology and Therapeutics. ,vol. 21, pp. 453- 461 ,(1998) , 10.1046/J.1365-2885.1998.00174.X
Timothy J. Strelevitz, Michael C. Linhares, Simultaneous determination of danofloxacin and N-desmethyldanofloxacin in cattle and chicken edible tissues by liquid chromatography with fluorescence detection Journal of Chromatography B: Biomedical Sciences and Applications. ,vol. 675, pp. 243- 250 ,(1996) , 10.1016/0378-4347(95)00354-1
M Ismail, YA El-Kattan, None, Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves. Research in Veterinary Science. ,vol. 82, pp. 398- 404 ,(2007) , 10.1016/J.RVSC.2006.10.001